The influence on prostaglandin synthetase system by 1-aryl-4-carboxy-2-pyrrolidones in relation to their pharmacological activity.
D000700:Analgesics / Q000494:pharmacology; D000818:Animals; D001241:Aspirin / Q000494:pharmacology; D004487:Edema / Q000517:prevention & control; D005334:Fever / Q000517:prevention & control; D008297:Male; D008861:Microsomes / Q000201:enzymology; D006899:Mixed Function Oxygenases / Q000378:metabolism*; D009097:Multienzyme Complexes / Q000378:metabolism*; D011453:Prostaglandins / Q000378:metabolism / Q000494:pharmacology*; D011760:Pyrrolidinones / Q000494:pharmacology*; D012669:Seminal Vesicles / Q000201:enzymology
D000700:Analgesics; D009097:Multienzyme Complexes; D011453:Prostaglandins; D011760:Pyrrolidinones; D006899:Mixed Function Oxygenases; D001241:Aspirin